Palavra-chave: PRAZIQUANTEL

MORPHOMETRY BIOMARKERS TRATAMENTO CICLODEXTRINA ESQUISTOSSOMOSE COMPLEXO DE INCLUSÃO CYTOTOXICITY LIPIDS CYCLODEXTRIN SCHISTOSOMA MANSONI, MORPHOLOGY DRUG DELIVERY SYSTEM SCHISTOSOMIASIS DRUG-DELIVERY FEBANTEL INCLUSION COMPLEX NUCLEAR MAGNETIC RESONANCE HIPERBÁRICA STRAINS PIRANTEL SHISTOSOMIASIS LIPIDEOS MOLECULAR MODELLING BLENDAS COMPLEX INCLUSION SOLID LIPID NANOPARTICLES ANTIPARASITÁRIO DRUG DELIVERY MOLECULAR MODELING NMR PZQ-RESISTANT METHYL BETA CYCLODEXTRIN SCHISTOSOMA MANSONI LIBERAÇÃO CONTROLADA DE DROGAS BIOLOGICAL ACTIVITY NANOPARTÍCULAS LIPÍDICAS SÓLIDAS BETA-CICLODEXTRINA BIOMARCADORES CICLODEXTRINAS CÃES HEPG2 CELLS MALDI-MSI IN VITRO MASS SPECTROMETRY IMAGING LIPOSSOMAS RESISTÊNCIA NANOTECHNOLOGY BLENDAS DE DEXTRANO METILBETACICLODEXTRINA LIPOSOMES SHISTOSOMÍASE SUSCEPTIBILITY SCHISTOSOMIASIS MANSONI NANOSTRUCTURED LIPID CARRIERS RESISTENCE